postnatally. 4, 8, 9 Outcome and clinical features for CHDs diagnosed in utero are important both for prenatal counseling and perinatal management. In this retrospective study, therefore, we have attempted to establish the clinical features and outcome for fetal CHD in a Taiwanese tertiary care medical center to determine the ethnic variation.
Materials and Methods
A total of 339 fetal patients, referred for fetal echocardiographic examination and who were delivered at National Taiwan University Hospital between January 1995 and December 2000, were enrolled in this retrospective study. Fetal echocardiography was performed using two-dimensional pulsed Doppler (Sonolayer 270A®; Toshiba, Tokyo, Japan). Where indicated, color Doppler (XP120; Acuson, Mountain View, CA, USA) was also used for homodynamic assessment. A pediatric cardiologist examined most of the enrolled fetuses. Segmental analysis for cardiac situs, pulmonary venous return, atrial and ventricular chambers, cardiac valves, ventriculo-arterial connections and aortic and ductal arches were performed in all the cases. Echocardiography, angiography, ultrafast computed tomography, surgery and/or autopsy were utilized for postnatal diagnosis. Data with respect to the indications for fetal echocardiography, maternal age, gravida, para, prenatal diagnosis, chromosomal and extracardiac anomalies, postnatal diagnosis and outcome were obtained by reviewing the medical records.
STATA software version 7.0 (Stata Corp., College Station, TX, USA) was used for statistical analysis based on χ 2 and Fisher's exact tests. Kaplan and Meier nonparametric estimation was used to generate survival curves. 10 
Results
Of the 726 fetuses examined using fetal echocardiography, 387 who were subsequently delivered at other hospitals were excluded from this study. Of the remaining 339 fetuses delivered at our institution, 103 had cardiac abnormalities. The outcomes for the study population are depicted in Figure 1 . The reasons for the referral and subsequent findings are presented in Table 1 . Of the 124 cases referred by the obstetrician because of suspected fetal CHD, the diagnosis was confirmed in 79 (63.7%). The most common indication for referral was abnormal appearance of the heart on ultrasound, as noted by the obstetrician (36.6%) and family history of CHD (25.7%). Structural heart defects were diagnosed in three fetuses (3.4%) scanned because of family history of CHD as follows: tuberous sclerosis in the mother and one sibling of a fetus with cardiac rhabdomyoma; a right atrial isomerism in a sibling also identified in an enrolled fetus; and aortic stenosis diagnosed in the mother of a neonate with a postnatally detected ostium secundum defect.
Of the 103 cases of CHD, 42 (40.8%) had survived after follow-ups ranging from 1 week to 6 years. The type of heart defect and outcome for the affected fetuses are summarized in Table 2 . Thirty fetuses (29.1%) were terminated, with only three (2.9%) expiring in utero. Fifteen neonates (14.6%) died during the neonatal stage. Eleven children (10.7%) expired in infancy, two (1.9%) with right atrial isomerism at the age of 1 year. Gestational age at diagnosis ranged from 17 to 40 weeks (mean, 27.8) and diagnosis was made before 24 weeks in 37 cases (35.9%), with 25 of these pregnancies subsequently terminated.
Chromosomal or extracardiac abnormalities were present in 25 (24%) fetuses (five had both). Cytogenetic analysis was conducted for 53 fetuses, with chromosomal abnormality detected in 15 cases (28.3%): trisomy 21 (n = 5); trisomy 18 (n = 3); and trisomy 13, mosaic trisomy 12, t(1;2) (p34.1;q27), 6p duplication, 10q25 deletion, 18p-, and 22q11 microdeletion (n = 1 each). Five pregnancies involving chromosomal abnormality were terminated. Death was the outcome in six of the 10 continued pregnancies, occurring in utero (n = 1), neonatally (n = 4), and in infancy/ childhood (n = 1).
Omitting the minor extracardiac anomalies (i.e. those without serious medical or cosmetic sequelae), 15 (14.6%) of the CHD cases involved concomitant major extracardiac structural abnormalities. Of these, five were multiple extracardiac anomalies. Major extracardiac anomalies consisted of lesions of the central nervous system (n = 6), genitourinary (n = 6), respiratory (n = 3), gastrointestinal (n = 3) and skeletal systems (n = 2), and cleft lip and palate (n = 1). Except for five fetuses with coexisting chromosomal anomalies, four with concomitant extracardiac anomalies were terminated (Table 3) . Three of the six continued pregnancies resulted in death of the fetus either in utero (n = 1) or neonatally (n = 2). Of the continued pregnancies, the overall mortality rate was high for both groups of extracardiac (normal karyotype; 3/6, 50%) and chromosomal anomalies (6/10, 60%).
Mortality rate was high in cases with isomerism, double-outlet right ventricle and hypoplastic left heart syndrome (64.3%, 57.1% and 100%, respectively). Survival curves for dominant types of CHD are presented in Figure 2 , with interventions and outcomes summarized below. Systemic-topulmonary shunts were installed in eight patients with right isomerism (modified and standard Blalock-Taussig or Glenn), with four of these expiring. Four patients with right isomerism underwent other surgical procedures including Table 3 . Incidence of associated extracardiac and chromosomal anomalies in CHD (n = 103) and outcome groups
Extracardiac anomalies 10 (10) 4 (13) 1 (33) 2 (13) 0 (0) 3 (7) (normal karyotype) Chromosomal anomalies 15 (15) 5 (17) coarctation repair (n = 2), total correction (n = 1) and total anomalous pulmonary venous connection repair (n = 1), with three of these not surviving. All six patients with hypoplastic left heart syndrome underwent Norwood operation (n = 3) and coarctation repair (n = 3), however, all expired. In contrast, all six patients with tetralogy of Fallot underwent total correction and survived. Three of the five patients with double-outlet right ventricle who underwent Blalock-Taussig shunt (n = 2), pulmonary artery banding (n = 1), pulmonary artery banding and coarctation repair (n = 1) and complete repair (n = 1) expired. Six patients with critical pulmonary stenosis/pulmonary atresia who underwent balloon valvuloplasty (n = 4) and transcatheter valvotomy (n = 2) survived. Cardiac arrhythmias was detected in 25 fetuses of the sample (Table 4) , five of whom had coexisting cardiac defects: long QT syndrome with perimembranous ventricular septal defect; atrial bigeminy with critical pulmonary stenosis (n = 1); paroxysmal supraventricular tachycardia with right atrial isomerism (n = 1); and complete atrioventricular (AV) block with postnatally detected atrial septal defect (n = 1). The most common arrhythmia was premature atrial contractions (44%); however, all fetuses with this arrhythmia showed good results. Mortality was high in long QT syndrome, with two of the three affected fetuses expiring postnatally due to intractable ventricular tachycardia at 4 days of age and suddenly at 10 months despite β-blocker treatment and pacemaker insertion at 1 month. The sole survivor had an uneventful postnatal course after initiation of treatment with potassium channel opener (nicorandil).
Complete AV block was detected in four fetuses. Two pregnancies involving hydrops fetalis in the second trimester were terminated. Both survivors had pacemakers implanted neonatally, with one treated in utero using digoxin. Systemic lupus erythematosus was detected in two of the four mothers.
Of the subgroup of non-surviving fetuses where postmortem examination was not performed, 14 pregnancy terminations and two intrauterine deaths also involved CHD, while two Down syndrome and one AV block did not. Excluding the above cases, the sensitivity and specificity of fetal echocardiography for major cardiac defects were 96.6% and 99.1%, respectively. Three CHD fetuses, with small ventricular septal defect, small aortic coarctation and critical pulmonary stenosis, were not detected prenatally. Two neonates with normal postnatal echocardiography findings had false prenatal diagnoses of critical pulmonary stenosis/ pulmonary atresia at 35 weeks' gestation.
Discussion
In the present study, the most common indication for fetal echocardiography was abnormal heart appearance on general fetal ultrasound examination (36.6%). High incidence (63.7%) of CHD was noted where the cardiac abnormality was detected at the general obstetric ultrasound examination. The four-chamber view of the heart has been recommended as part of obstetric ultrasound evaluation, 11 with a high rate of cardiac malformations noted in cases referred because of suspicious four-chamber views. 4, 6 The mean gestational age at CHD diagnosis was 27.8 weeks in our patient series, compared to 27.9, 26 and 26.5/22.7 weeks in studies conducted in Italy, New York and London (1983/1992), respectively. Further, 35.9% of cardiac malformations were detected prior to 24 weeks' gestation in this study, compared to 43%, 46% and 68%, respectively, in the research above. 4, 8, 12 The higher rate of early detection in the United Kingdom reflects an almost universal routine scanning policy in that country at 17-22 weeks of gestation. 1 In Taiwan, however, although ultrasound scan is used for most fetuses, cardiac evaluation is not always included. It appears reasonable to suggest, therefore, that where possible, fetal cardiac evaluation (four-chamber view of the fetal heart as a minimum) be part of the obstetric scan prior to 24 weeks' gestation in all pregnancies. In our study, the proportion of extracardiac/ chromosomal anomalies was 14.6%/28.3%, whereas the analogous rates were 32%/28%, 19.1%/19.6% and 16%/9% in the Yale, Italian and New York series, respectively. 4, 8, 12 The lower incidence of extracardiac anomalies in our study may reflect the practice of the obstetrician with respect to terminating a pregnancy with extracardiac anomalies without routine referral to the pediatric cardiologist for examining the fetal heart. 13 Because of the low rate (51%) of chromosome analysis in our target population, the correct rate of chromosome anomalies would be within the range of 14.6% (15/103) and 28.3% (15/51). Structural heart defects were detected in only three (3.4%) of our fetuses with family history of CHD. The recurrence risk for a subsequent pregnancy where a sibling has been diagnosed with an isolated heart defect in this study was similar to the general reported incidence (2-4%).
14 Heterotaxy syndrome was the most common type of prenatally detected CHD in our sample and even in our excluded cases (Tables 2 and 5 ). However, ventricular septal defect and tetralogy of Fallot were the predominant types of postnatally detected CHD in Taiwan. 15 Brick and Allanstated that the spectrum of prenatally detected CHD is often different from that seen postnatally. This may result from the high prenatal detection rate and larger proportion of prenatal loss in severe, complex cardiac anomalies. Further, the spectrum of prenatally detected CHD in our study differed from other reports, 3 17 Thus, it appears reasonable to speculate that the high ratio of right atrial isomerism in our study may also be related to ethnicity. The outcome for our fetuses with major CHD (e.g. isomerism, hypoplastic left heart syndrome and double-outlet right ventricle) remained poor, except in cases of critical pulmonary stenosis and pulmonary atresia with intact septum. Analogous high mortality rates for these CHD variants in other studies were 80-81%, 55-100% and 25-100%, respectively. 3, 4, 6, 8, 13 However, our 0% mortality for pulmonary stenosis/atresia contrasts markedly with the relatively higher rate reported elsewhere (27-46%). 3, 8, 13 Early prostaglandin infusion and postnatal interventional cardiac catheterization improved the prognosis in our cases of critical pulmonary stenosis/atresia. 19, 20 Five of seven fetuses with prenatally detected ventricular septal defects also had poor prognosis in this study ( Figure 2) ; four of these with ventricular septal defects had concomitant serious extracardiac anomalies, arrhythmia or trisomy. Further, the greater likelihood that large defects will be diagnosed prenatally may account for the difference in prognosis compared to postnatally detected analogues. In the present study, the overall mortality was higher where there were associated chromosomal or extracardiac anomalies (60% and 50%, respectively), with mortality also high in the neonatal stage. Elevated mortality rates, especially in utero and in the neonatal stage, with concomitant chromosomal or extracardiac anomalies have been reported in several studies. 3, 4, 8 In our sample, fetuses with isolated arrhythmias (except long QT syndrome or hydrops fetalis) had good prognosis. The former exception is frequently associated with familial transmission and is characterized primarily by prolongation of the Q-T interval and occurrence of life-threatening tachyarrhythmias. 21 Family history and electrocardiography for family members may be helpful for prenatal differential diagnosis in fetuses with unexplained ventricular tachycardia with AV block. 22, 23 One false negative and two false positive diagnoses of pulmonary stenosis/atresia occurred in fetuses scanned in the third trimester. Poor image quality at late gestational age may have contributed to these errors. Although cardiac size increases with fetal age, maternal obesity, fetal lie with spine in the anterior position, calcified ribs and oligohydramnios at late gestational age will limit the image quality and make interpretation difficult. 24 About 53% of the examined cases were excluded from the present study, inevitably generating selection bias in terms of the outcome and subtype distribution of fetuses with CHD. For example, as some of the excluded cases may have been delivered in local hospitals or clinics where the quality of care and/or equipment levels may be somewhat inferior to medical centers, arguably impacting on prognosis, therefore, their prognosis may have been worse compared to those delivered in medical centers. Thus, taking into account both the excluded and enrolled fetuses with prenatally detected CHD, the outcome may be inferior compared to the studied sample. Although our investigation was limited in terms of universal applicability for Taiwan as a whole, this retrospective study may provide an important reference for prenatal consultation, providing information relevant to prediction of the outcome for prenatally detected CHD in Taiwan.
In summary, overall outcome for our sample of fetuses with CHD detected prenatally in Taiwan remained poor despite in utero detection. Complex lesions, and associated extracardiac or chromosomal anomalies negatively impacted prognosis. In contrast, prognosis was generally good for isolated arrhythmias, with the exception of long QT syndrome and hydrops fetalis. The abnormally high proportion of heterotaxy syndrome and right atrial isomerism in Taiwan may be due to ethnic variation.
